The Oncology Institute, Inc. (STLN) — Net Asset Quality Index
The Oncology Institute, Inc. (STLN) has a Net Asset Quality Index of -14.0% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $178.23 Million minus total liabilities of $203.15 Million yields net assets of $-24.91 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check asset allocation strategy of The Oncology Institute, Inc. to assess the company's strategic physical and investment asset allocation.
Quality Index
Net Assets
Total Assets
Total Liabilities
The Oncology Institute, Inc. Net Asset Quality Index Over Time (2022–2025)
This chart shows how The Oncology Institute, Inc.'s Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the index stands at -14.0%, representing net assets of $-24.91 Million against total assets of $178.23 Million USD. Explore STLN capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Net Asset Quality Index for The Oncology Institute, Inc. (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for The Oncology Institute, Inc. from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is The Oncology Institute, Inc. worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -9.5% | $-15.72 Million | $164.66 Million | $180.38 Million | ▼ -11.6 pp |
| 2024 | 2.1% | $3.59 Million | $172.72 Million | $169.13 Million | ▼ -25.2 pp |
| 2023 | 27.3% | $57.02 Million | $209.24 Million | $152.22 Million | ▼ -19.8 pp |
| 2022 | 47.1% | $123.17 Million | $261.67 Million | $138.49 Million | — |